Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony sti...
Q2 2026
Aug 6, 2026
Q1 2026
May 11, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 6, 2025